GENOVAC NANO Trademark

Trademark Overview


On Tuesday, June 14, 2022, a trademark application was filed for GENOVAC NANO with the United States Patent and Trademark Office. The USPTO has given the GENOVAC NANO trademark a serial number of 97457305. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by Genovac Antibody Discovery LLC. The GENOVAC NANO trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Biomanufacturing for others, namely, manufacturing of antibodies, proteins, and plasmids using biological organisms in the manufacturing process

Biotechnology research; Pharmaceutical research and development; Pharmaceutical research services; Development of new technology for others in the field of biotechnology and pharmaceuticals; Laboratory research services relating to pharmaceuticals; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
genovac nano

General Information


Serial Number97457305
Word MarkGENOVAC NANO
Filing DateTuesday, June 14, 2022
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7177988
Registration DateTuesday, September 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements


Goods and ServicesBiomanufacturing for others, namely, manufacturing of antibodies, proteins, and plasmids using biological organisms in the manufacturing process
Disclaimer with Predetermined Text"NANO"
Goods and ServicesBiotechnology research; Pharmaceutical research and development; Pharmaceutical research services; Development of new technology for others in the field of biotechnology and pharmaceuticals; Laboratory research services relating to pharmaceuticals; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, June 27, 2022
Primary Code040
First Use Anywhere DateMonday, November 22, 2021
First Use In Commerce DateWednesday, June 15, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 27, 2022
Primary Code042
First Use Anywhere DateMonday, November 22, 2021
First Use In Commerce DateWednesday, June 15, 2022

Trademark Owner History


Party NameGenovac Antibody Discovery LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFargo, ND 58102

Party NameGenovac Antibody Discovery LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFargo, ND 58102

Party NameGenovac Antibody Discovery LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFargo, ND 58102

Trademark Events


Event DateEvent Description
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, August 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 21, 2023USE AMENDMENT FILED
Tuesday, July 18, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 21, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, February 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, February 13, 2023ASSIGNED TO EXAMINER
Monday, June 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 17, 2022NEW APPLICATION ENTERED